Leukotriene D 4 (LTD 4 ), 1 a metabolite of arachidonate via the 5-lipoxygenase pathway, has biological activities such as bronchial constriction and increase in vascular permeability. It is related to the onset and progression of bronchial asthma and other allergic disorders (1-3). Although the cell-surface LTD 4 receptor is presumed to be a seven-transmembrane receptor coupling to a heterotrimeric GTP-binding protein(s) (G protein(s)) (4, 5), it has not yet been purified or cDNA-cloned. Moreover, cellular events that evoke various biological effects have not been clarified. We report here that in human monocytic THP-1 cells, LTD 4 increased the intracellular calcium concentration and activated MAP kinase through a PTX-insensitive G protein, PKC␣ and Raf-1 pathway. Furthermore, THP-1 cells showed a chemotaxis toward LTD 4 through a PTXsensitive G protein. Thus, LTD 4 receptors have at least two signal transduction pathways in THP-1 cells, the PTX-insensitive MAP kinase cascade and the PTX-sensitive pathway leading to chemotaxis.
Leukotriene D 4 (LTD
) is a major lipid mediator involved in inflammatory and allergic disorders including bronchial asthma. Despite its potent biological activity, little is known about the receptor and intracellular signaling pathways. Here we analyzed the signal transduction mechanisms through LTD 4 receptors using human monocytic leukemia THP-1 cells. When these cells were stimulated with LTD 4 , intracellular calcium concentration was increased and mitogen-activated protein kinase (MAP kinase) was activated severalfold. This activation was inhibited by staurosporine or GF109203X treatment or abolished by protein kinase C depletion. Cytosolic protein kinase C␣ was translocated to the membrane, and Raf-1 was activated by LTD 4 Leukotriene D 4 (LTD 4 ), 1 a metabolite of arachidonate via the 5-lipoxygenase pathway, has biological activities such as bronchial constriction and increase in vascular permeability. It is related to the onset and progression of bronchial asthma and other allergic disorders (1) (2) (3) . Although the cell-surface LTD 4 receptor is presumed to be a seven-transmembrane receptor coupling to a heterotrimeric GTP-binding protein(s) (G protein(s)) (4, 5) , it has not yet been purified or cDNA-cloned. Moreover, cellular events that evoke various biological effects have not been clarified. We report here that in human monocytic THP-1 cells, LTD 4 increased the intracellular calcium concentration and activated MAP kinase through a PTX-insensitive G protein, PKC␣ and Raf-1 pathway. Furthermore, THP-1 cells showed a chemotaxis toward LTD 4 Probond resin was from Invitrogen (NV Leek, The Netherlands). Protein A-agarose CL-4B and glutathione-Sepharose 4B were from Pharmacia Biotech (Uppsala, Sweden). BAPTA/AM and Fura-2/AM were from Dojin (Kumamoto, Japan). Pertussis toxin (PTX) was from Funakoshi (Tokyo), and wortmannin was from Kyowa Medex Co (Tokyo). Tyrphostin, methyl 2,5-dihydroxycinnamate, and genistein were from Life Technologies, Inc. Anti-Raf-1 antibody (C-12) and anti-PKC␦ antibody (C-20) were from Santa Cruz Biotechnology (Santa Cruz, CA). Anti-Erk2 antibody was from Upstate Biotechnology (Lake Placid, NY). Bovine serum albumin fraction V (fatty acid-free) was from Bayer (Kankakee, IL). Polycarbonate filters with 8-m pores were from Neuroprobe (Cabin John, MD). A Diff-Quick staining kit was from International Reagents Corp. (Kobe, Japan). MK-571 was from Biomol (Plymouth Meeting, PA). Protein determination reagents (BCA kit) were from Pierce. Other chemicals and reagents were of analytical grade. ONO-1078 was a kind gift from Ono Pharmaceutical Co (Osaka, Japan). A His-tagged MAP kinase kinase and a GST fusion kinase-negative (GSTkn) MAP kinase were generous gifts from Drs. Y. Gotoh and E. Nishida (Kyoto University).
Measurement of Intracellular Ca 2ϩ Concentrations-THP-1 cells suspended in Hepes-Tyrode's-BSA buffer (Hepes-Tyrode's-BSA buffer contains the following: 140 mM NaCl, 2.7 mM KCl, 1.8 mM CaCl 2 , 0.49 mM MgCl 2 , 12 mM NaHCO 3 , 5.6 mM D-glucose, 0.37 mM NaH 2 PO 4 , 10 mM Hepes-NaOH (pH 7.4), containing 0.1% (w/v) of fatty acid-free BSA) were loaded with 3 M Fura-2/AM at 37°C for 1 h, washed twice, and resuspended in Hepes-Tyrode's-BSA buffer to a concentration of 1.0 ϫ 10 7 cells/ml. After 5 min of stirring at 37°C, ligands were added, and elevations in intracellular Ca 2ϩ concentrations were measured using a spectrofluorometer (model CAF-100, JASCO, Tokyo), with emission wavelength set at 510 nm and excitation wavelengths at 340 and 380 nm.
Measurement of Cyclic AMP-Cells were seeded on 24-well dishes 24 h prior to start of experiments. After aspirating off the medium, the cells were incubated for 20 min in Hepes-Tyrode's-BSA buffer containing 0.5 mM 3-isobutyl-1-methylxanthine at 37°C. Next, the cells were exposed for 20 min to 50 M forskolin in the presence of ligands. The supernatant was aspirated after centrifugation, and the reaction was terminated by adding 200 l of 30% perchloric acid. After a 20-min incubation, the supernatant was collected by centrifugation. The concentrations of cyclic AMP (cAMP) in the supernatant were determined using a radioimmunoassay kit from Yamasa (Chiba, Japan).
MAP Kinase Assay-Aliquots (3.0 ϫ 10 6 cells in 1 ml of HepesTyrode's-BSA buffer) of serum-starved cells were stimulated with ligands at 37°C. The supernatant was aspirated after centrifugation, and the reaction was terminated by adding an ice-cold lysis buffer containing 20 mM Tris-HCl (pH 8.0), 20 mM ␤-glycerophosphate, 1 mM sodium orthovanadate, 2 mM EGTA, 2 mM dithiothreitol (DTT), 1 mM phenylmethylsulfonyl fluoride (PMSF), and 10 g/ml aprotinin (final concentration) in a total volume of 200 l. Aliquots were then assayed for the MAP kinase as described previously (6) . When examining the effects of PTX, cells were incubated overnight with 100 ng/ml PTX.
PKC Translocation Analysis-Aliquots (3.0 ϫ 10 6 cells in 1 ml of Hepes-Tyrode's-BSA buffer) of serum-starved cells were stimulated with ligands at 37°C. The supernatant was aspirated after centrifugation, and the reaction was terminated by adding an ice-cold lysis buffer (20 mM Tris-HCl (pH 8.0), 10 mM EGTA, 2 mM EDTA, 2 mM DTT, 1 mM PMSF, 10 g/ml aprotinin). After sonication at 30 watts for 30 s and removal of the nuclei and unbroken cells by centrifugation (1,000 ϫ g for 15 min), the supernatant was further centrifuged at 100,000 ϫ g for 60 min to obtain the cytosol (supernatant) and the membrane (pellet) fractions. The pellet was extracted with the lysis buffer containing 1% Triton X-100 and sonicated. After leaving on ice for 30 min, the membrane extract was obtained by centrifugation at 10,000 ϫ g for 30 min. Proteins were separated on a 10% SDS-PAGE gel and transferred onto Hybond-Nϩ membranes. After blocking the membrane with 10% BSA, immunoblot analysis was performed with an anti-PKC antibody. Blots were visualized with ECL detection reagents.
Raf-1 Analysis-A His-tagged MAP kinase kinase and a GST-kn MAP kinase were expressed in Escherichia coli and purified by column chromatography as described (7). Aliquots (3.0 ϫ 10 6 cells in 1 ml of Hepes-Tyrode's-BSA buffer) of serum-starved cells were stimulated with ligands at 37°C. The supernatant was aspirated after centrifugation, and the reaction was terminated by adding an ice-cold lysis buffer containing 20 mM Tris-HCl (pH 8.0), 137 mM NaCl, 20 mM ␤-glycerophosphate, 1 mM sodium orthovanadate, 2 mM EGTA, 2 mM DTT, 1 mM PMSF, 10 g/ml aprotinin, 10% glycerol, 1% Triton X-100, and 0.1% SDS. The homogenates were centrifuged at 10,000 ϫ g for 15 min, and the supernatants were precleared with 70 l of 1:1 slurry of protein A-Sepharose beads. They were then incubated for 2 h with 20 l of an anti-Raf-1 antibody and 70 l of 1:1 slurry of protein A-Sepharose beads at 4°C. The immune complex on the beads was washed three times with the lysis buffer, twice with a solution containing 100 mM Tris-HCl (pH 8.0) and 0.5 M LiCl, and once with a solution containing 20 mM Tris-HCl (pH 8.0), 2 mM EGTA, and 10 mM MgCl 2 . This preparation was referred to as the immunoprecipitate.
To assay Raf-1 kinase toward an exogenous substrate, the Histagged MAP kinase kinase (1.5 g) and the GST-kn MAP kinase (2.5 g) were incubated with the immunoprecipitate at 30°C in a 24-l solution containing 20 mM Tris-HCl (pH 8.0), 2 mM EGTA, 10 mM MgCl 2 , and 100 M [␥-32 P]ATP (370 kBq). The reaction was stopped by adding Laemmli's sample buffer and boiling. After SDS-PAGE separation, the radioactivity incorporated in the His-tagged MAP kinase kinase or the GST-kn MAP kinase was detected and quantified using an image analyzer (Fujix BAS 2000) .
Chemotaxis Assay-Polycarbonate filters with 8-m pores were coated with 10 g/ml fibronectin in phosphate-buffered saline for 60 min. A dry coated filter was placed on a 96-blind well chamber containing the indicated amounts of LTD 4 , and the THP-1 cells (200 l, 1.0 ϫ 10 6 cells) were added to the top wells. The ligand solution and cell suspension were prepared in the same buffer (RPMI 1640 medium containing 0.1% BSA). After incubation at 37°C in 5% CO 2 for 4 h, the filter was disassembled. Cells on the filter were fixed with methanol and stained with a Diff-Quick staining kit. The upper side of the filter was then scraped free of cells. The number of cells that had migrated to the lower side was determined by measuring optical densities at 595 nm using a 96-well microplate reader (Bio-Rad model 3550) (8) . 4 Receptors in THP-1 Cells-The membrane fractions of THP-1 cells were examined in a binding assay as described (4, 9) . (Fig. 1A) . ONO-1078, a specific LTD 4 receptor antagonist (10, 11) , inhibited the response (Fig. 1A) . 100 nM LTD 4 induced an increase in intracellular calcium concentration about 250 nM above basal levels (Fig. 1B) . Pretreatment of the cells with PTX reduced the LTD 4 -elicited calcium response by 30% and the ATP-elicited response by 20%, whereas it did not inhibit the thrombin-elicited calcium response (data not shown). Next, we determined the effects of LTD 4 on cAMP accumulation. LTD 4 dosedependently inhibited the forskolin-induced cAMP accumulation with an IC 50 value of 100 nM and did not increase cAMP level in the absence of forskolin (data not shown). This inhibitory effect of LTD 4 was completely blocked by PTX or by ONO-1078 pretreatment (data not shown), indicating that the LTD 4 receptor couples to PTX-sensitive G protein(s). These data show that LTD 4 receptors are functionally active in THP-1 cells and couple to both PTXsensitive and -insensitive G proteins.
RESULTS

Occurrence of LTD
MAP Kinase Activation after LTD 4 Stimulation-We then investigated LTD 4 -induced signal transduction mechanisms in THP-1 cells. After stimulation with 100 nM LTD 4 , the bands of MAP kinase (Erk2) were time-dependently gel-shifted in the immunoblot analysis ( Fig. 2A) . This gel shift became most evident 5 min after LTD 4 stimulation. MAP kinase assay with an epidermal growth factor receptor peptide as a substrate showed a severalfold activation with 100 nM LTD 4 (data not shown). As shown in Fig. 2B , the EC 50 value of MAP kinase activation was about 0.1 nM, and the activation was saturable at a higher dose (higher than 1 nM). When cells were pretreated with MK-571 or ONO-1078, both specific antagonists for the LTD 4 receptor (Cys-LTR 1 , see Ref. 12), LTD 4 did not elicit the MAP kinase activation (Fig. 2B) . These data suggest that the LTD 4 -elicited MAP kinase activation is Cys-LTR 1 -mediated.
Effects of Inhibitors on MAP Kinase Activation-Next, effects of various inhibitors on LTD 4 -elicited MAP kinase activation were examined. When the cells were pretreated overnight with PTX, the LTD 4 -elicited MAP kinase activation was slightly inhibited (Fig. 3) . Treatment of the cells with BAPTA/AM (intracellular calcium chelator) inhibited the enzyme activity by half (Fig. 3) . Pretreatment with a nanomolar order of wortmannin (phosphatidylinositol 3-kinase inhibitor) (13-15) or with several nonreceptor type tyrosine kinase inhibitors (i.e. tyrphostin, methyl 2,5-dihydroxycinnamate, and genistein) did not inhibit the LTD 4 -elicited MAP kinase activation (data not shown). 10 M or 30 M GF109203X or 300 nM staurosporine, both inhibitors of protein kinase C (PKC), inhibited LTD 4 -elicited MAP kinase activation (Fig. 3) . We thus considered that PKC might be involved in LTD 4 -elicited MAP kinase activation. To confirm this notion, cells were pretreated overnight with TPA to deplete endogenous PKCs. MAP kinase activation by LTD 4 was completely blocked by this treatment (Fig. 3) . Thus, in THP-1 cells, LTD 4 receptors mediate MAP kinase activation via a signaling pathway that may depend on the activity of PKCs.
Translocation of PKC␣ and PKC␦ following LTD 4 Stimulation-We then examined which PKC isozyme is involved in the signaling pathway. PKC␣ and PKC␦ were detected in THP-1 cells by immunoblot analysis. In the resting state, almost all PKC␣ and PKC␦ were present in the cytosol, but 100 nM LTD 4 caused a translocation of PKC␣ and PKC␦ from the cytosol to the membrane in 10 min (Fig. 4, A and B) . As a positive control, TPA also caused a translocation of PKC␣ and PKC␦ from the cytosol to the membrane. This translocation of PKC␣ was inhibited by pretreatment with BAPTA/AM but that of PKC␦ was not affected by the same pretreatment (data not shown).
Involvement of Raf-1 in MAP Kinase Activation-Finally, we examined the role of Raf-1 in LTD 4 -elicited MAP kinase activation. After stimulation with LTD 4 , THP-1 cells were treated with the ice-cold lysis buffer, and the lysates were immunoprecipitated with an anti-Raf-1 antibody. The Raf-1 immunoprecipitate activated the His-tagged MAP kinase kinase and the GST-kn MAP kinase by about 2-fold in several minutes (Fig.  5A) . When cells were pretreated overnight with TPA to deplete endogenous PKC␣, the Raf-1 immunoprecipitate failed to activate the exogenous substrates (Fig. 5B) . These data strongly suggest that activation of Raf-1 by PKC␣ plays a dominant role in LTD 4 -elicited MAP kinase activation.
LTD 4 -induced Chemotaxis-It has been reported that LTD 4 induces a chemotaxis of eosinophils (16, 17) . Thus, we examined whether LTD 4 would induce a chemotaxis of THP-1 cells. As shown in Fig. 6 , LTD 4 did induce chemotaxis in THP-1 cells with the maximal response at 30 nM. After the cells were pretreated overnight with PTX, the LTD 4 -induced chemotaxis completely disappeared (Fig. 6 ). These data indicate that LTD 4 -stimulated chemotaxis occurs through a PTX-sensitive mechanism. DISCUSSION LTD 4 is produced from arachidonic acid, triggered by the activation of 5-lipoxygenase. LTD 4 together with other cysteinyl LTs constitute a slow reacting substance of anaphylaxis, a major mediator in bronchial asthma and various allergic disorders (1-3). We and others (4, 5) previously provided indirect evidence that the LTD 4 receptor couples to heterotrimeric G protein(s) in the cells and mobilizes intracellular calcium (18) . However, the biochemical properties of the LTD 4 receptor are unknown, and intracellular signaling mechanisms through the LTD 4 receptor are not well understood. This is mostly because only scanty numbers of LTD 4 receptors are expressed in the cells, and suitable cell lines that respond strongly to LTD 4 stimulation have not been readily available. We studied various macrophage and monocytic cell lines (RAW264.7, P388D 1 , J774A.1, PU5-1.8, THP-1 cells, etc.) by examining the LTD 4 -induced calcium response and MAP kinase activation. Among them, a human monocytic leukemia cell line, THP-1 cells, showed most obvious responses toward LTD 4 . THP-1 cells exhibited a specific binding to LTD 4 , an increase in intracellular calcium concentration, and activation of MAP kinase. By comparing the potency of LTD 4 and (5S,6R,7E,9E,11Z,14Z)-5-hydroxy-6-(S-glutathionyl)-icosatetraen-1-oic acid (LTC 4 ) (data not shown), the receptor expressed on the THP-1 cell membranes can be classified as Cys-LTR 1 (12) . To our knowledge, this is the first detailed description of MAP kinase activation by LTD 4 . Since MAP kinase is a key enzyme that transmits signals from the cell surface to the nucleus (19) and activates several molecules including a cytosolic phospholipase A 2 (20) , we further studied the mechanisms of how LTD 4 caused an activation of MAP kinase. The MAP kinase is activated by a variety of extracellular stimuli, including those mediated by receptor tyrosine kinases and by G protein-coupled receptors (21) (22) (23) (24) . The mechanisms from the G protein-coupled receptors to MAP kinase involve one or more molecules as follows: PKC (22, 25) , Pyk2 (26 -28), or phosphatidylinositol 3-kinase (29) , depending on the cell types or ligands. Some experiments were performed using receptor overexpression systems, and this may differ from the native cells possessing endogenous receptors. In this study we provided evidence that LTD 4 receptors couple to the PTX-insensitive G protein (G q or G 11 ) and cause a transient intracellular calcium mobilization, which in turn activates PKC␣ and Raf-1, a well-known MAP kinase kinase kinase. The involvement of G q , PKC␣, and Raf-1 in this sequence was demonstrated by the following observations. 1) The activations of MAP kinase and PKC␣ were scarcely inhibited by PTX treatment (Fig. 3, data not shown) , although inhibition of adenylate cyclase was completely restored by the same treatment (data not shown). 2) LTD 4 induced a translocation of PKC␣ from the cytosol to the membrane and activation of Raf-1 (Figs. 4A and 5A). 3) The LTD 4 -elicited MAP kinase activation was inhibited by staurosporine or GF109203X but not by wortmannin or tyrosine kinase inhibitors (Fig. 3 , data not shown).
4) The activation of Raf-1 and MAP kinase was inhibited by PKC depletion in the cells (Fig. 3 and Fig. 5B ). Moreover, calcium-independent PKC␦ was also translocated by LTD 4 in a similar time course (Fig. 4B) , and this may be also the consequence of an elevation in diacylglycerol levels through a G qphospholipase C ␤ pathway.
To date, the role of MAP kinase in macrophages/monocytic cells remains elusive. The activation of cytosolic phospholipase A 2 may yield a production of various eicosanoids (i.e. prostaglandins or leukotrienes) or platelet-activating factor, which either amplify or regulate inflammatory reactions (30, 31) . Furthermore, MAP kinase activation may induce various genes that relate to tumoricidal or bactericidal activity of macrophages.
Another finding in this study relates to the chemotactic activity of LTD 4 in THP-1 cells. LTD 4 has been considered to function as a potent chemoattractant for human eosinophils (16, 17) . Considering that chemotactic responses by other ligands, such as interleukin-8 (32, 33), C5a (34) , and LTB 4 (8) , are also inhibited by PTX-pretreatment, the common molecule(s) probably locates downstream of G i -like protein(s).
In conclusion, THP-1 cells have functional LTD 4 receptors (Cys-LTR 1 ) that couple to both G q -like and G i -like proteins. LTD 4 activates MAP kinase mostly through a G q , PKC␣, and Raf-1 pathway, whereas the chemotactic response is mediated through G i -like protein. THP-1 cells proved to be an appropriate cell line for elucidation of LTD 4 -induced cellular signaling as well as for purification of the Cys-LTR 1 molecules.
